Glenmark Pharmaceuticals has received USFDA approval for Azelaic Acid gel used in treatment of acne. The gel Azelaic Acid Gel, 15 per cent, is a generic version of Finacea Gel (15 per cent) of Leo Pharma.
According to market estimates the gel has an estimated annual sales potential of approximately USD 64.1 million. Glenmark has a portfolio comprising 143 products authorized for distribution in the US market and 56 ANDAs pending approval with the USFDA.
Company Profile : Glenmark Pharma Ltd
Leave a Reply